Your browser doesn't support javascript.
loading
Experts consensus statement on Cheezheng Xiaotong Tiegao in clinical practice / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 629-635, 2019.
Article in Chinese | WPRIM | ID: wpr-777515
ABSTRACT
Cheezheng Xiaotong Tiegao is a Tibetan traditional prescription,which has the functions of promoting blood circulation,relieving swelling and relieving pain. It has been widely used in various clinical departments such as orthopedics department,rheumatology department,pain management department,and rehabilitation department to treat all types of acute and chronic skeletal muscle pain. However,duet to the lack of detailed description of the specific use of various diseases in its manual,and in the published guidelines,monographs,and clinical reports,the introduction of the dominant clinical disease,usage,treatment,safety,etc. of Cheezheng Xiaotong Tiegao is not detailed. Therefore,this experts consensus statement has been prepared based on the research and analysis of clinicians and patients,evidence-based medical research and evaluation,combined with the experience of clinical experts. The experts consensus statement regulates usage,dosage,combination,safety,etc. in the treatment of acute and chronic contusion( soft tissue injury),osteoarthritis,low back pain,frozen shoulder,cervical spondylosis postoperative recovery pain and other pain relief and other skeletal muscle system diseases to provide evidence and reference for the rational and safety using of Cheezheng Xiaotong Tiegao.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pain / Consensus / Edema Type of study: Practice guideline Limits: Humans Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pain / Consensus / Edema Type of study: Practice guideline Limits: Humans Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2019 Type: Article